- Home
- GTX vs VCEL Comparison
GTX vs VCEL Comparison
Compare GTX & VCEL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- GTX
- VCEL
- Stock Information
- Founded
- GTX 2018
- VCEL 1989
- Country
- GTX Switzerland
- VCEL United States
- Employees
- GTX N/A
- VCEL N/A
- Industry
- GTX Auto Parts:O.E.M.
- VCEL Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- GTX Consumer Discretionary
- VCEL Health Care
- Exchange
- GTX Nasdaq
- VCEL Nasdaq
- Market Cap
- GTX 2.6B
- VCEL 2.1B
- IPO Year
- GTX N/A
- VCEL 1997
- Fundamental
- Price
- GTX $12.85
- VCEL $36.28
- Analyst Decision
- GTX Strong Buy
- VCEL Strong Buy
- Analyst Count
- GTX 1
- VCEL 7
- Target Price
- GTX $14.00
- VCEL $61.29
- AVG Volume (30 Days)
- GTX 2.5M
- VCEL 619.6K
- Earning Date
- GTX 07-24-2025
- VCEL 07-31-2025
- Dividend Yield
- GTX 1.86%
- VCEL N/A
- EPS Growth
- GTX 42.92
- VCEL 2045.40
- EPS
- GTX 1.43
- VCEL 0.13
- Revenue
- GTX $3,461,000,000.00
- VCEL $249,119,000.00
- Revenue This Year
- GTX $2.10
- VCEL $23.03
- Revenue Next Year
- GTX $0.23
- VCEL $24.51
- P/E Ratio
- GTX $9.04
- VCEL $271.43
- Revenue Growth
- GTX N/A
- VCEL 16.13
- 52 Week Low
- GTX $7.02
- VCEL $33.09
- 52 Week High
- GTX $13.32
- VCEL $63.00
- Technical
- Relative Strength Index (RSI)
- GTX 65.10
- VCEL 44.74
- Support Level
- GTX $12.44
- VCEL $35.24
- Resistance Level
- GTX $12.91
- VCEL $38.08
- Average True Range (ATR)
- GTX 0.31
- VCEL 1.87
- MACD
- GTX -0.06
- VCEL 0.02
- Stochastic Oscillator
- GTX 53.95
- VCEL 36.71
About GTX Garrett Motion Inc.
Garrett Motion Inc designs, manufactures and sells engineered turbocharger and electric-boosting technologies for light and commercial vehicle original equipment manufacturers (OEMs). The company is a technology leader with expertise in delivering products across gasoline, diesel, natural gas and electrified powertrains. The company also sells its technologies in the aftermarket through its distribution network. The company derives maximum of its revenue from Gas and geographically from Europe.
About VCEL Vericel Corporation
Vericel Corp is a fully integrated, commercial-stage biopharmaceutical company and a provider of therapies for the sports medicine and severe burn care markets. It markets cell therapy products in the United States, MACI (autologous cultured chondrocytes on porcine collagen membrane); Epicel (cultured epidermal autografts); and NexoBrid. The Company operates its business in the U.S. in one reportable segment; the research, product development, manufacture, and distribution of cellular therapies and specialty biologics for use in the treatment of specific conditions.